Nerve endings (n = 1,298) on noradrenaline cells in adrenal medullas of male rats (n =117) were investigated by quantitative electron microscopy, with sampling at 8 times during a standardized light:dark (12:12) photo-period cycle. Numbers per unit area were determined for synaptic vesicles of two types, small clear vesicles (SCVN) and large granular vesicles (LGVN); from these the percent of LGV per total vesicle number was calculated. In non-operated animals mean SCVN had two cycles per day, with acrophases near the middle of the light and dark phases and troughs near the times of change in lighting; there were also significant peaks (at start and middle of dark phase) and troughs in mean LGVN. Sham-operated (SPX) animals had decreased or insignificant signs of rhythmic changes in these two vesicle types; reduction was most marked in SCVN after SPX. Pinealectomized (PX) differed from non-operated animals in apparent losses of the cyclic changes in SCVN in the dark phase and in LGVN at the start of the dark phase; the former could have been due to a desynchronization of the dark phase rhythm in SCVN in the absence of the pineal. Nerve endings on A-cells and N-cells differed consistently and significantly in the quantitative relations and rhythmic patterns of their two major kinds of synaptic vesicles. These differences, and those seen after pinealectomy or sham surgery, indicate that both the neuroendocr¡ne and preganglionic mechanisms regulating the chromaffin cells have temporal and quantitative characteristics that differ in relation to major type of chromaffin cell affected.

Keywords:
Adrenal medulla, Cholinergic nerve ending, Circadian rhythm, Pinealectomy, Synaptic vesicle number, Ultradian rhythm
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.